Clinical trial · Observational
Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With Radioclinical Characterization
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The management of pelvic gynecological cancers (PGC) is based on the determination of extension to guide treatments. The biology of the CGP is constantly evolving and personalized medicine adapted to this biology is currently in full development. For example, sequencing ovarian tumors can select patients who can benefit from anti-PARP therapy. There is therefore a need for patients to have biological samples of their tumor. Various studies on ovarian, endometrial and cervical cancer have sought to identify the factors predictive of recurrence of these cancers. The results obtained are very promising. This study will permit to collect biological samples and detailed clinical data that would allow to test hypotheses and develop a personalized medicine based on clinical and biological characteristics of patients.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometriosis | — | UNRESOLVED | — |
| Pelvic Neoplasms | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| collection of sample and data | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Collection of sample and data
- description
- Collection of biological samples and clinical data
- interventionNames
- Other: collection of sample and data
Primary outcomes (2)
- measure
- circulating tumor and DNA
- timeFrame
- 2 years
- measure
- Endometriosis tumor and DNA
- timeFrame
- 2 years
Secondary outcomes (9)
- measure
- circulating tumor DNA
- timeFrame
- 5 years
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of pelvic gynecological cancer posed on initial histological analysis or during recurrence; * Or diagnosis of endometriosis on histology or imaging * Age ≥ 18 years; * Affiliation to the general social security scheme; * Consent signed. Exclusion Criteria: * Refusal of the patient; * Non-affiliation to the general social security scheme.
References
Publications (0)
Data not yet available